To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AURKATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
410 supporting clones for gene AURKA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BJ990238 hepatoblastoma .a 1 to 588 11 to 600   tiling clone,   590/600
(98 %)
6 diff
(99.0 %id)
BJ990239 hepatoblastoma .a 1946 to 2485 540 to 1   tiling clone,   540/540
(100 %)
1 diff
(99.9 %id)
BP350793   .b -9 to 573 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
D84212 blood .b 42 to 2117 56 to 2016 I57V A105H P106L E107K N108I ... tiling clone,   1820/2033
(89 %)
40 diff
(98.1 %id)
BQ066913 brain .c 1 to 659 1 to 660   tiling clone,   660/1004
(65 %)
12 diff
(98.9 %id)
BI560361 testis .c 14 to 805 1 to 795       795/938
(84 %)
29 diff
(97.0 %id)
BU940401 mixed (pool of 40 RNAs) .c 16 to 792 1 to 787       787/790
(99 %)
31 diff
(96.1 %id)
TI_44349008   .c 19 to 805 129 to 918       790/1061
(74 %)
30 diff
(97.2 %id)
DA734874   .c 31 to 731 2 to 711   capped   710/719
(98 %)
19 diff
(97.4 %id)
DA613873   .c 33 to 602 2 to 571   capped   570/572
(99 %)
4 diff
(99.4 %id)
DA650556   .c 33 to 589 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA264261 caudate nucleus .c 34 to 602 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
BG768121 melanotic melanoma, high MDR (cell line), skin .c 35 to 682 1 to 652       652/652
(100 %)
10 diff
(98.5 %id)
BU193183 eye, retinoblastoma .c 37 to 606 1 to 570       570/742
(76 %)
5 diff
(99.4 %id)
CN273679 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 39 to 304 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
BU181160 large cell carcinoma, lung .c 39 to 910 53 to 934   tiling clone,   879/934
(94 %)
32 diff
(96.6 %id)
BX375637 Neuroblastoma Cot 25-normalized .c 64 to 966 1 to 902   tiling clone,   902/902
(100 %)
4 diff
(99.6 %id)
BX375636 Neuroblastoma Cot 25-normalized .c 1242 to 2194 982 to 30   tiling clone,   953/982
(97 %)
1 diff
(99.9 %id)
DB367032   .c 1713 to 2259 548 to 1   tiling clone,   548/551
(99 %)
11 diff
(98.1 %id)
CB138172 Liver .d 1 to 434 1 to 433   tiling clone,   433/433
(100 %)
3 diff
(99.4 %id)
CB139273 Liver .d 1 to 416 1 to 415       415/415
(100 %)
7 diff
(98.4 %id)
NM_198436.1   .d 1 to 2229 1 to 2229 exact RefSeq,   2229/2231
(99 %)
5 diff
(99.8 %id)
DA419550 cord Blood .d 30 to 583 2 to 555   tiling clone, capped   554/554
(100 %)
2 diff
(99.7 %id)
BM458030 leiomyosarcoma, uterus .d 56 to 948 13 to 905   tiling clone,   893/1031
(86 %)
10 diff
(99.1 %id)
DA563465 heart .d 66 to 633 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BC027464 Kidney, hypernephroma .d 77 to 2223 1 to 2147 I57V tiling clone, available from MGC, AAA   2147/2147
(100 %)
1 diff
(100.0 %id)
BG164674 hypernephroma, cell line, Kidney .d 78 to 810 1 to 737       737/1003
(73 %)
22 diff
(97.9 %id)
DB452494 testis .d 81 to 562 1 to 482       482/483
(99 %)
4 diff
(99.2 %id)
DA666161   .d 82 to 618 2 to 538   capped   537/545
(98 %)
3 diff
(99.5 %id)
DA705415   .d 82 to 619 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA750573   .d 82 to 653 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB043043 testis .d 82 to 645 2 to 565   capped   564/565
(99 %)
2 diff
(99.7 %id)
DB046120 testis .d 83 to 654 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DW423541 Liver .d 90 to 368 13 to 291       279/291
(95 %)
6 diff
(98.0 %id)
BQ424806 melanotic melanoma, skin .d 90 to 927 36 to 879       844/888
(95 %)
15 diff
(98.4 %id)
DA903709   .d 93 to 531 2 to 440   capped   439/439
(100 %)
1 diff
(99.8 %id)
DB009492 colon, tumor tissue .d 96 to 661 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DN997910 breast cancer, Mammary gland (cancer tissue) .d 101 to 440 1 to 340       340/340
(100 %)
9 diff
(97.4 %id)
BX354785 Neuroblastoma Cot 25-normalized .d 102 to 1089 1 to 988       988/988
(100 %)
4 diff
(99.6 %id)
BF306950 muscle, rhabdomyosarcoma .d 102 to 813 1 to 706       706/941
(75 %)
20 diff
(97.9 %id)
CA455185   .d 104 to 1030 1 to 919       919/919
(100 %)
13 diff
(98.6 %id)
BI088164 cervix .d 112 to 1039 1 to 921       921/922
(99 %)
36 diff
(96.1 %id)
BX338066 Placenta Cot 25-normalized .d 129 to 943 6 to 820       820/820
(100 %)
5 diff
(99.4 %id)
BE293249 adenocarcinoma cell line, colon .d 135 to 776 1 to 643       641/643
(99 %)
10 diff
(98.5 %id)
BG611661 adenocarcinoma, Prostate .d 176 to 947 1 to 783       781/798
(97 %)
34 diff
(95.8 %id)
BX338065 Placenta Cot 25-normalized .d 1188 to 2192 997 to 1       997/1000
(99 %)
10 diff
(99.0 %id)
BX354784 Neuroblastoma Cot 25-normalized .d 1197 to 2189 988 to 1       988/1005
(98 %)
7 diff
(99.4 %id)
DA647694   .e 1 to 558 2 to 559   tiling clone, capped   558/559
(99 %)
2 diff
(99.7 %id)
DB448688 testis .e 15 to 437 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
DB193598 ovary, tumor tissue .e 16 to 590 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB256225 uterus .e 16 to 581 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BC001280 Cervix, carcinoma .e 34 to 2145 1 to 2112 I57V tiling clone, available from MGC, AAA   2112/2112
(100 %)
1 diff
(100.0 %id)
CX782043 human embryonic stem cells .e 34 to 832 1 to 799       799/799
(100 %)
1 diff
(99.9 %id)
CX782008 human embryonic stem cells .e 1570 to 2145 600 to 25   AAA   576/576
(100 %)
2 diff
(99.7 %id)
BP224535   .f 1 to 583 1 to 583   tiling clone,   583/583
(100 %)
5 diff
(99.2 %id)
NM_198435.1   .f 43 to 2175 1 to 2133 exact RefSeq,   2133/2135
(99 %)
5 diff
(99.8 %id)
BU171303 leiomyosarcoma, uterus .f 69 to 929 1 to 863       863/863
(100 %)
4 diff
(99.6 %id)
DB032566 testis .f 90 to 622 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA539606 Kidney .f 93 to 686 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
BP221217 colon .f 101 to 665 1 to 565       565/565
(100 %)
9 diff
(98.5 %id)
DA574853   .f 108 to 662 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA644155   .f 112 to 678 9 to 575   capped   567/567
(100 %)
2 diff
(99.7 %id)
CD704304 normal nasopharynx .f 118 to 675 15 to 571       557/571
(97 %)
12 diff
(97.9 %id)
BF218050 brain, glioblastoma .f 122 to 720 1 to 597       597/876
(68 %)
11 diff
(98.8 %id)
BG498945 adenocarcinoma, Prostate .f 122 to 532 1 to 411       411/411
(100 %)
2 diff
(99.6 %id)
AK312776 testis .f 123 to 1401 1 to 1279 F31I I57V S284P     1279/1279
(100 %)
3 diff
(99.8 %id)
DB052925 testis .f 124 to 692 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BP243753 Liver .f 125 to 697 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BI462731 testis .f 125 to 865 8 to 759       752/881
(85 %)
29 diff
(96.8 %id)
DB033682 testis .f 131 to 709 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DW418503 Liver .f 133 to 534 18 to 420       403/424
(95 %)
10 diff
(97.7 %id)
DA732703   .f 137 to 732 2 to 595   capped   594/596
(99 %)
19 diff
(96.9 %id)
DA907620   .f 138 to 699 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BG719004 testis .f 141 to 970 10 to 838       829/840
(98 %)
20 diff
(97.7 %id)
BG116309 duodenal adenocarcinoma, cell line, small intestine .f 142 to 894 1 to 746       746/965
(77 %)
19 diff
(98.1 %id)
BI086920 cervix .f 145 to 957 1 to 816       816/816
(100 %)
10 diff
(98.8 %id)
TI_154179501   .f 148 to 894 73 to 817       745/797
(93 %)
7 diff
(99.2 %id)
TI_154179639   .f 148 to 973 70 to 891       822/825
(99 %)
19 diff
(97.7 %id)
BU177242 melanotic melanoma, skin .f 149 to 1102 1 to 953       953/953
(100 %)
11 diff
(98.9 %id)
BX425271 neuroblastoma .f 151 to 1220 1 to 1065       1065/1065
(100 %)
11 diff
(99.0 %id)
CR621289 HeLa cells Cot 25-normalized .f 151 to 2142 1 to 1992 exact tiling clone,   1992/1992
(100 %)
0 diff
(100 %id)
BX363007   .f 151 to 1169 1 to 1009       1009/1013
(99 %)
14 diff
(98.7 %id)
CX166006 human embryonic stem cells differentiated toan early endodermal cell type .f 151 to 967 1 to 817       817/817
(100 %)
1 diff
(99.9 %id)
BM801959 eye, retinoblastoma .f 152 to 712 1 to 564       564/1172
(48 %)
11 diff
(99.1 %id)
AU132739   .f 157 to 1020 2 to 865   capped   864/869
(99 %)
15 diff
(98.3 %id)
DN998754 bone marrow .f 158 to 937 1 to 780       780/780
(100 %)
6 diff
(99.3 %id)
BQ435059 leiomyosarcoma, uterus .f 169 to 1031 1 to 864       864/864
(100 %)
3 diff
(99.7 %id)
T36134 testis .f 169 to 454 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
CN273684 embryonic stem cells, DMSO-treated H9 cellline .f 173 to 921 1 to 749       749/749
(100 %)
1 diff
(99.9 %id)
DR760436 embryonic stem .f 179 to 994 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
BX411769 neuroblastoma .f 1316 to 2165 853 to 1       853/912
(93 %)
31 diff
(96.7 %id)
AU154211   .f 1643 to 2169 527 to 1       527/529
(99 %)
2 diff
(99.7 %id)
AU150020   .f 1668 to 2169 502 to 1   tiling clone,   502/502
(100 %)
13 diff
(97.5 %id)
NM_003600.2   .g 1 to 2344 1 to 2344   RefSeq,   2344/2346
(99 %)
5 diff
(99.8 %id)
DB020008 testis .g 82 to 573 2 to 493   tiling clone, capped   492/492
(100 %)
1 diff
(99.8 %id)
DB031450 testis .g 89 to 700 2 to 613   capped   612/612
(100 %)
1 diff
(99.9 %id)
AL711075 human skeletal muscle .g 91 to 689 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
DA903030   .g 96 to 663 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BG757310 B-cells, primary B-cells from tonsils (cell line) .g 102 to 816 1 to 720       720/980
(73 %)
19 diff
(98.1 %id)
AF011468 breast .g 103 to 2339 1 to 2237 F31I I57V tiling clone, AAA   2237/2237
(100 %)
2 diff
(100.0 %id)
DB011831 esophageal, tumor tissue .g 106 to 673 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DR761625 embryonic stem .g 108 to 710 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
DN997715 breast cancer, Mammary gland (cancer tissue) .g 112 to 681 1 to 570       570/574
(99 %)
5 diff
(99.2 %id)
CX865672 embryonic stem .g 138 to 860 21 to 743       723/743
(97 %)
7 diff
(99.1 %id)
CX762843 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 138 to 870 1 to 732     Submitted on the opposite strand 732/732
(100 %)
5 diff
(99.4 %id)
BE900514 choriocarcinoma, placenta .g 141 to 971 1 to 837       837/838
(99 %)
25 diff
(97.1 %id)
CX787203 human embryonic stem cells .g 144 to 887 1 to 744       744/744
(100 %)
1 diff
(99.9 %id)
DA030271   .g 154 to 725 2 to 576   tiling clone, capped   575/575
(100 %)
3 diff
(99.5 %id)
BE746826 adenocarcinoma cell line, ovary .g 196 to 677 63 to 562       500/649
(77 %)
28 diff
(95.7 %id)
DA985723 synovial membrane tissue from rheumatioidarthritis .g 263 to 821 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
CR616247 T cells (Jurkat cell line) .h 1 to 1841 1 to 1841 exact tiling clone,   1841/1841
(100 %)
0 diff
(100 %id)
BX447877 T cells (Jurkat cell line) .h 10 to 1082 8 to 1070   fully sequenced,   1063/1070
(99 %)
19 diff
(98.3 %id)
BX447876 T cells (Jurkat cell line) .h 1052 to 1818 797 to 25   fully sequenced,   773/797
(96 %)
13 diff
(98.4 %id)
BF062086 pooled germ cell tumors .h 1187 to 1869 682 to 1       682/686
(99 %)
23 diff
(96.7 %id)
H63889 liver and spleen .h 1191 to 1407 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
AI126792 heart .h 1198 to 1868 673 to 1       673/673
(100 %)
7 diff
(99.0 %id)
BE092461 breast .h 1200 to 1511 13 to 324       312/326
(95 %)
8 diff
(97.6 %id)
H72166 liver and spleen .h 1200 to 1491 1 to 293       293/293
(100 %)
7 diff
(97.7 %id)
BE092286 breast .h 1201 to 1527 328 to 2     Submitted on the opposite strand 327/328
(99 %)
0 diff
(100 %id)
H57643 liver and spleen .h 1204 to 1596 1 to 400       400/400
(100 %)
11 diff
(97.3 %id)
CD617261   .h 1216 to 1929 708 to 4       705/708
(99 %)
0 diff
(100 %id)
R97567 liver and spleen .h 1221 to 1311 1 to 91       91/91
(100 %)
2 diff
(97.9 %id)
AI884785 anaplastic oligodendroglioma, brain .h 1232 to 1876 645 to 2       644/650
(99 %)
0 diff
(100 %id)
R96793 liver and spleen .h 1249 to 1555 1 to 307       307/312
(98 %)
3 diff
(99.1 %id)
CA416232 Chondrosarcoma Cell line .h 1249 to 1869 637 to 17   AAA   621/621
(100 %)
0 diff
(100 %id)
CA428604 cell lines, Chondrosarcoma .h 1257 to 1874 635 to 18   AAA   618/618
(100 %)
1 diff
(99.9 %id)
AW516673 cervix, tumor .h 1306 to 1876 571 to 1       571/571
(100 %)
1 diff
(99.9 %id)
BE811513 amnion_normal .h 1307 to 1512 1 to 204       204/204
(100 %)
3 diff
(98.6 %id)
W78726 liver and spleen .h 1318 to 1801 1 to 487       487/487
(100 %)
3 diff
(99.4 %id)
TI_154016443   .h 1330 to 2145 893 to 89   AAA   805/944
(85 %)
17 diff
(98.2 %id)
BE547389 cervical carcinoma cell line, cervix .h 1347 to 2116 1 to 762       762/779
(97 %)
22 diff
(97.2 %id)
AV702128 adrenal gland .h 1364 to 1848 1 to 485       485/485
(100 %)
0 diff
(100 %id)
H78488 liver and spleen .h 1366 to 1748 1 to 392       392/448
(87 %)
16 diff
(96.5 %id)
BE011847 breast_normal .h 1372 to 1543 173 to 3     Submitted on the opposite strand 171/176
(97 %)
0 diff
(100 %id)
AI638439 pooled germ cell tumors .h 1381 to 1869 489 to 1       489/489
(100 %)
0 diff
(100 %id)
BE779679 eye, retinoblastoma .h 1386 to 2129 1 to 747       747/770
(97 %)
22 diff
(97.2 %id)
BI860726 breast, mammary adenocarcinoma, cell line .h 1396 to 2058 28 to 698       671/698
(96 %)
6 diff
(99.2 %id)
TI_57192300   .h 1396 to 2058 80 to 750       671/698
(96 %)
6 diff
(99.2 %id)
AA834453 adenocarcinoma, colon .h 1409 to 1794 387 to 2       386/387
(99 %)
0 diff
(100 %id)
AW136695   .h 1420 to 1873 471 to 18   AAA   454/454
(100 %)
2 diff
(99.6 %id)
BM840359 lymph node, stomach .h 1420 to 1899 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
BM841444 lymph node, stomach .h 1420 to 1989 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
BF510691   .h 1424 to 1869 461 to 16   AAA   446/460
(96 %)
1 diff
(99.8 %id)
AI004050   .h 1434 to 1870 441 to 6       436/441
(98 %)
0 diff
(100 %id)
AI207188 pooled germ cell tumors .h 1440 to 1873 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AW365050 denis_drash .h 1442 to 1773 332 to 1       332/332
(100 %)
4 diff
(98.8 %id)
AW014897   .h 1447 to 1891 15 to 459     Submitted on the opposite strand 445/459
(96 %)
6 diff
(98.7 %id)
BM790362 Ascites, stomach .h 1459 to 2016 1 to 558       558/558
(100 %)
0 diff
(100 %id)
AI689761 carcinoid, lung .h 1462 to 2019 1 to 558     Submitted on the opposite strand 558/558
(100 %)
1 diff
(99.9 %id)
BE767265 nervous_tumor .h 1480 to 1624 147 to 2       146/149
(97 %)
0 diff
(100 %id)
BE767267 nervous_tumor .h 1480 to 1621 144 to 1       144/146
(98 %)
5 diff
(96.6 %id)
BQ343430 nervous_tumor .h 1481 to 1646 1 to 165       165/169
(97 %)
14 diff
(91.8 %id)
AA767736 germinal center B cell .h 1481 to 1870 398 to 9       390/398
(97 %)
0 diff
(100 %id)
AI738674 colon, colon tumor, RER+ .h 1487 to 1869 383 to 1       383/383
(100 %)
0 diff
(100 %id)
BI093745 cervix .h 1490 to 2145 1 to 656   AAA   656/656
(100 %)
4 diff
(99.4 %id)
BG250804 adenocarcinoma, cell line, Liver .h 1493 to 2145 1 to 650       650/665
(97 %)
6 diff
(99.1 %id)
BU624433 cell lines, Enchondroma .h 1509 to 2145 656 to 19   AAA   638/638
(100 %)
1 diff
(99.9 %id)
BQ774895 Bone, Human Chondrosarcoma Cell Line .h 1509 to 2145 655 to 19   tiling clone, AAA   637/637
(100 %)
0 diff
(100 %id)
EC498163 Prostate .h 1516 to 1595 80 to 1       80/90
(88 %)
1 diff
(98.9 %id)
CA424075 cell lines, Chondrosarcoma .h 1529 to 2145 636 to 19   AAA   618/618
(100 %)
1 diff
(99.9 %id)
R19158 liver and spleen .h 1530 to 1870 349 to 4       346/357
(96 %)
0 diff
(100 %id)
CA437209 lung, Metastatic Chondrosarcoma .h 1534 to 2145 630 to 19   AAA   612/612
(100 %)
1 diff
(99.9 %id)
EC481167 Prostate .h 1552 to 1651 99 to 2       98/99
(98 %)
0 diff
(100 %id)
EC519652 Prostate .h 1555 to 1650 99 to 3       97/99
(97 %)
0 diff
(100 %id)
BU185193 ductal carcinoma, cell line, Pancreas .h 1556 to 2143 1 to 588   AAA   588/588
(100 %)
1 diff
(99.9 %id)
EC440452 Prostate .h 1557 to 1651 95 to 1       95/99
(95 %)
0 diff
(100 %id)
EC500392 Prostate .h 1557 to 1650 94 to 1       94/95
(98 %)
0 diff
(100 %id)
EC515695 Prostate .h 1557 to 1650 100 to 1       100/101
(99 %)
6 diff
(94.1 %id)
EC557653 Prostate .h 1557 to 1649 93 to 1       93/93
(100 %)
0 diff
(100 %id)
TI_154171871   .h 1611 to 2145 641 to 107   AAA Submitted on the opposite strand 535/535
(100 %)
4 diff
(99.3 %id)
BG769326 melanotic melanoma, high MDR (cell line), skin .h 1618 to 2145 1 to 528   AAA   528/528
(100 %)
4 diff
(99.3 %id)
BE503915 pooled germ cell tumors .h 1624 to 2145 528 to 6       523/528
(99 %)
0 diff
(100 %id)
AA629662 lung, lung carcinoma .h 1630 to 2145 526 to 12   AAA   515/515
(100 %)
3 diff
(99.5 %id)
CF141169 CNCAP(3)T-225 cell line, Prostate .h 1642 to 2145 538 to 35   AAA Submitted on the opposite strand 504/504
(100 %)
2 diff
(99.7 %id)
CN273682 embryonic stem cells, DMSO-treated H9 cellline .h 1646 to 2142 9 to 506       498/506
(98 %)
6 diff
(98.9 %id)
TI_154128810   .h 1671 to 2145 564 to 90   AAA   475/720
(65 %)
5 diff
(99.4 %id)
CA417669 Chondrosarcoma Cell line .h 1675 to 2145 489 to 19   AAA   471/473
(99 %)
3 diff
(99.4 %id)
AA602467 adrenal adenoma, adrenal gland .h 1681 to 2145 469 to 5       465/469
(99 %)
0 diff
(100 %id)
BE465533 malignant melanoma, metastatic to lymphnode, skin .h 1682 to 2145 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
AI859635 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 1683 to 2145 464 to 2       463/464
(99 %)
0 diff
(100 %id)
AI828708 ovary, tumor, 5 pooled (see description) .h 1686 to 2145 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI859629 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 1686 to 2145 461 to 2       460/461
(99 %)
0 diff
(100 %id)
AI148444   .h 1689 to 2145 485 to 29   AAA   457/457
(100 %)
2 diff
(99.6 %id)
AI652950 pooled germ cell tumors .h 1693 to 1873 182 to 2       181/182
(99 %)
0 diff
(100 %id)
N58083 liver and spleen .h 1695 to 2145 459 to 1       459/463
(99 %)
11 diff
(97.7 %id)
R97724 liver and spleen .h 1697 to 2140 449 to 1       449/449
(100 %)
8 diff
(98.3 %id)
DB518375 testis .h 1702 to 2145 1 to 444     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
BE243218 leukopheresis .h 1706 to 2143 440 to 3       438/440
(99 %)
0 diff
(100 %id)
AI318096 adenocarcinoma, colon .h 1715 to 2145 435 to 5       431/435
(99 %)
0 diff
(100 %id)
AA704673 liver and spleen .h 1719 to 2145 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
AI318060 adenocarcinoma, colon .h 1721 to 2145 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
BE465518 malignant melanoma, metastatic to lymphnode, skin .h 1726 to 2145 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
AA745859 germinal center B cell .h 1728 to 2145 426 to 10       417/426
(97 %)
0 diff
(100 %id)
AI026750   .h 1731 to 2145 425 to 10       416/425
(97 %)
0 diff
(100 %id)
AI266728 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1732 to 2145 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AW409660 muscle, rhabdomyosarcoma .h 1733 to 2152 445 to 26   tiling clone,   420/445
(94 %)
0 diff
(100 %id)
AA748628 germinal center B cell .h 1734 to 2145 421 to 10       412/421
(97 %)
0 diff
(100 %id)
H58486 liver and spleen .h 1753 to 2143 400 to 7       394/405
(97 %)
0 diff
(100 %id)
DB513826 testis .h 1778 to 2142 1 to 362     Submitted on the opposite strand 362/365
(99 %)
13 diff
(96.5 %id)
DB509368 testis .h 1781 to 2145 1 to 361     Submitted on the opposite strand 361/362
(99 %)
6 diff
(98.4 %id)
AA486497   .h 1783 to 2145 1 to 362   fully sequenced,   362/362
(100 %)
5 diff
(98.7 %id)
AI750284 Bone, Hip .h 1790 to 2108 326 to 8       319/326
(97 %)
0 diff
(100 %id)
H79032 liver and spleen .h 1793 to 2143 354 to 1       354/354
(100 %)
5 diff
(98.6 %id)
H54313 liver and spleen .h 1798 to 2145 351 to 3       349/354
(98 %)
0 diff
(100 %id)
H63492 liver and spleen .h 1804 to 2145 342 to 1       342/347
(98 %)
4 diff
(98.9 %id)
H78390 liver and spleen .h 1804 to 2144 341 to 1       341/347
(98 %)
3 diff
(99.2 %id)
AW272138 colon, moderately-differentiated adenocarcinoma .h 1807 to 2145 348 to 3       346/348
(99 %)
0 diff
(100 %id)
AA736853 germinal center B cell .h 1820 to 2145 334 to 9       326/334
(97 %)
0 diff
(100 %id)
AW594462 pooled germ cell tumors .h 1830 to 2145 319 to 2       318/319
(99 %)
0 diff
(100 %id)
R07581 liver and spleen .h 1837 to 2140 321 to 6       316/334
(94 %)
0 diff
(100 %id)
AI500164 lymph node, lymphoma, follicular mixed small and largecell .h 1873 to 2145 273 to 1       273/273
(100 %)
0 diff
(100 %id)
AA832386 germinal center B cell .h 1878 to 2145 276 to 9       268/276
(97 %)
0 diff
(100 %id)
AA598643   .h 1905 to 2145 241 to 1       241/241
(100 %)
12 diff
(95.1 %id)
AA488685   .h 1959 to 2145 215 to 29   fully sequenced, AAA   187/187
(100 %)
0 diff
(100 %id)
W80533 liver and spleen .h 1962 to 2145 184 to 1       184/184
(100 %)
0 diff
(100 %id)
EC473966 Prostate .h 2046 to 2144 103 to 3       101/103
(98 %)
0 diff
(100 %id)
FN051225 breast carcinoma .h 2052 to 2143 1 to 90       90/94
(95 %)
2 diff
(97.9 %id)
NM_198434.1   .i 1 to 2243 1 to 2243 exact RefSeq,   2243/2245
(99 %)
5 diff
(99.8 %id)
DB246909   .i 40 to 580 2 to 542   tiling clone, capped   541/545
(99 %)
4 diff
(99.3 %id)
BM751906 Ascites, stomach .i 81 to 561 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
DB051077 testis .i 82 to 651 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB039875 testis .i 83 to 663 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA731296   .i 90 to 870 2 to 783   tiling clone, capped   782/782
(100 %)
7 diff
(99.2 %id)
BG574357.
matches multiple genes
breast, Breast, mammary adenocarcinoma., mammary adenocarcinoma, cell line .i 100 to 761 13 to 674   available from MGC, also hits gene HIBADH 662/674
(98 %)
12 diff
(98.3 %id)
BU839659 hepatocellular carcinoma, cell line, Liver .i 100 to 861 1 to 767       767/918
(83 %)
11 diff
(98.9 %id)
DA885205   .i 101 to 667 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CN273677 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 102 to 790 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
AL518529 brain, neuroblastoma, neuroblastoma cells .i 102 to 1108 1 to 1001   tiling clone,   1001/1004
(99 %)
10 diff
(99.1 %id)
AA375986 lung .i 106 to 299 1 to 194       194/194
(100 %)
0 diff
(100 %id)
CN273678 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 111 to 816 1 to 706       706/706
(100 %)
3 diff
(99.6 %id)
BI093627 cervix .i 111 to 940 11 to 842       832/853
(97 %)
32 diff
(96.3 %id)
BE397008 Burkitt lymphoma, lymph .i 112 to 764 1 to 650       650/651
(99 %)
7 diff
(99.0 %id)
BG746486 adenocarcinoma cell line, colon .i 129 to 962 1 to 843       843/877
(96 %)
19 diff
(97.9 %id)
BG824487 adenocarcinoma cell line, colon .i 129 to 927 1 to 817       817/818
(99 %)
41 diff
(95.0 %id)
AL518528 brain, neuroblastoma, neuroblastoma cells .i 1146 to 2213 1068 to 10   tiling clone,   1059/1079
(98 %)
11 diff
(99.0 %id)
AU149424   .i 1753 to 2237 486 to 1   tiling clone,   486/486
(100 %)
7 diff
(98.6 %id)
BP245060 Kidney .j 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
3 diff
(99.5 %id)
NM_198437.1   .j 3 to 2121 1 to 2119 exact RefSeq,   2119/2121
(99 %)
5 diff
(99.8 %id)
DB023984 testis .j 27 to 576 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
DA753828   .j 57 to 604 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB116807 thymus .j 64 to 587 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DB039401 testis .j 67 to 650 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA616389   .j 68 to 663 2 to 598   capped   597/597
(100 %)
3 diff
(99.5 %id)
DB056693 testis .j 68 to 617 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
CD700643 normal nasopharynx .j 71 to 586 42 to 555       514/555
(92 %)
7 diff
(98.8 %id)
DB035522 testis .j 72 to 630 8 to 566   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
BI462572 testis .j 78 to 917 1 to 847       846/848
(99 %)
22 diff
(97.5 %id)
BI461490 testis .j 78 to 840 1 to 761       761/767
(99 %)
19 diff
(97.6 %id)
CR611278 neuroblastoma .j 80 to 2104 1 to 2025 exact     2025/2025
(100 %)
0 diff
(100 %id)
AL516768 brain, neuroblastoma, neuroblastoma cells .j 80 to 1074 1 to 988   fully sequenced,   988/988
(100 %)
5 diff
(99.5 %id)
BF029182 bladder, carcinoma, cell line .j 80 to 674 1 to 600       600/846
(70 %)
23 diff
(97.3 %id)
BP326937 prostata .j 83 to 655 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DA471474   .j 84 to 657 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA543090   .j 84 to 346 2 to 264   capped   263/263
(100 %)
2 diff
(99.3 %id)
DA891238 rectum .j 84 to 622 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
DB017999 esophageal, tumor tissue .j 84 to 624 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
DB052229 testis .j 84 to 628 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DN998129 breast cancer, Mammary gland (cancer tissue) .j 85 to 671 9 to 595       587/595
(98 %)
9 diff
(98.5 %id)
DB054430 testis .j 91 to 668 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DW443019 Liver .j 92 to 308 13 to 232       220/232
(94 %)
10 diff
(95.7 %id)
DW465355 Liver .j 92 to 437 13 to 358       346/358
(96 %)
8 diff
(97.8 %id)
DA904142   .j 92 to 658 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CD696463 normal nasopharynx .j 93 to 617 20 to 545       526/545
(96 %)
10 diff
(98.2 %id)
DW432496 Liver .j 93 to 340 18 to 265       248/265
(93 %)
8 diff
(97.0 %id)
AA305997   .j 96 to 545 1 to 451       451/451
(100 %)
2 diff
(99.6 %id)
DB452914 testis .j 96 to 599 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
DA038644   .j 97 to 658 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AU120266 whole embryo, mainly body .j 97 to 835 2 to 738   capped   737/737
(100 %)
9 diff
(98.8 %id)
BI093570 cervix .j 100 to 808 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BU167148 melanotic melanoma, skin .j 101 to 976 1 to 880       880/880
(100 %)
12 diff
(98.7 %id)
BF304720 muscle, rhabdomyosarcoma .j 102 to 798 1 to 689       689/875
(78 %)
27 diff
(97.0 %id)
DA051614   .j 103 to 654 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AA305070 colon .j 106 to 472 1 to 367       367/367
(100 %)
2 diff
(99.5 %id)
AA243152 brain, neuroepithelial cells .j 107 to 404 1 to 298       298/298
(100 %)
2 diff
(99.4 %id)
BC006423 Muscle, rhabdomyosarcoma .j 111 to 2115 1 to 2005 I57V tiling clone, available from MGC, AAA   2005/2005
(100 %)
1 diff
(100.0 %id)
CD617260   .j 131 to 523 175 to 570       397/399
(99 %)
11 diff
(97.3 %id)
BE295752 muscle, rhabdomyosarcoma .j 131 to 458 1 to 330       330/668
(49 %)
6 diff
(99.2 %id)
BE296227 muscle, rhabdomyosarcoma .j 131 to 818 1 to 684       684/684
(100 %)
10 diff
(98.6 %id)
BG168689 hypernephroma, cell line, Kidney .j 131 to 840 1 to 712       712/976
(72 %)
9 diff
(99.1 %id)
BI868220 adenocarcinoma, cell line, Liver .j 131 to 798 4 to 674       674/674
(100 %)
9 diff
(98.7 %id)
TI_57227873   .j 131 to 798 56 to 726       674/674
(100 %)
9 diff
(98.7 %id)
AF008551   .j 136 to 1347 1 to 1212 exact     1212/1212
(100 %)
1 diff
(100.0 %id)
BM013166 brain, neuroblastoma, cell line .j 138 to 595 1 to 459       459/459
(100 %)
4 diff
(99.2 %id)
TI_59382418   .j 138 to 595 108 to 566       459/459
(100 %)
4 diff
(99.2 %id)
BE882118 leiomyosarcoma, uterus .j 154 to 917 1 to 756       756/834
(90 %)
11 diff
(98.7 %id)
Z43879 brain, total brain .j 158 to 458 1 to 301       301/302
(99 %)
4 diff
(98.7 %id)
BI086328 cervix .j 211 to 900 1 to 694       694/694
(100 %)
8 diff
(98.9 %id)
AU124236   .j 233 to 990 2 to 753   capped   752/806
(93 %)
8 diff
(99.1 %id)
BU171595 melanotic melanoma, skin .j 242 to 1091 1 to 868       863/873
(98 %)
53 diff
(94.0 %id)
BU154704 melanotic melanoma, skin .j 244 to 1109 1 to 870       870/870
(100 %)
9 diff
(99.0 %id)
BU179459 epithelioid carcinoma, Pancreas .j 250 to 1121 1 to 878       878/878
(100 %)
8 diff
(99.1 %id)
BE785170 large cell carcinoma, lung .j 270 to 987 1 to 712       712/933
(76 %)
18 diff
(98.1 %id)
CB121994 Liver .j 287 to 699 1 to 416       416/427
(97 %)
4 diff
(99.1 %id)
AA313688 colon .j 321 to 840 1 to 520       520/527
(98 %)
1 diff
(99.9 %id)
BP269330 thyroid .j 329 to 903 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DA893944 skeletal muscle .j 352 to 922 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BX372079   .j 380 to 1311 930 to 1       930/930
(100 %)
4 diff
(99.6 %id)
BG284757 adenocarcinoma, cell line, Prostate .j 394 to 1145 1 to 744       744/746
(99 %)
9 diff
(98.8 %id)
BU521208 leiomyosarcoma, uterus .j 406 to 730 1 to 325       325/325
(100 %)
0 diff
(100 %id)
BG027837 Bone, osteosarcoma, cell line .j 426 to 1166 1 to 739       739/1010
(73 %)
11 diff
(99.0 %id)
AW409753 muscle, rhabdomyosarcoma .j 464 to 977 20 to 533       514/533
(96 %)
6 diff
(98.9 %id)
BQ685975 ductal carcinoma, cell line, Pancreas .j 477 to 1431 1 to 958       958/961
(99 %)
25 diff
(97.4 %id)
BG290257 bladder, transitional cell papilloma, cell line .j 480 to 1273 1 to 793       793/859
(92 %)
33 diff
(96.2 %id)
BM752324 Ascites, stomach .j 484 to 954 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BM752453 Ascites, stomach .j 484 to 1013 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
AA298501 lung .j 489 to 758 1 to 270       270/270
(100 %)
0 diff
(100 %id)
AW957623   .j 496 to 1166 1 to 670       670/730
(91 %)
25 diff
(96.6 %id)
CX782148 human embryonic stem cells .j 497 to 1289 1 to 793       793/793
(100 %)
0 diff
(100 %id)
BE299015 muscle, rhabdomyosarcoma .j 539 to 1166 1 to 629       629/635
(99 %)
3 diff
(99.6 %id)
AU124034   .j 540 to 1350 2 to 811   capped   810/810
(100 %)
2 diff
(99.8 %id)
CN273676 embryonic stem cells, DMSO-treated H9 cellline .j 554 to 942 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
CA488875   .j 560 to 1400 1 to 848       848/855
(99 %)
10 diff
(98.9 %id)
BG108532 Bone, osteosarcoma, cell line .j 592 to 1166 1 to 586       586/780
(75 %)
21 diff
(97.4 %id)
BG027828 Bone, osteosarcoma, cell line .j 593 to 1277 13 to 695       683/1055
(64 %)
20 diff
(98.2 %id)
CN273685 embryonic stem cells, DMSO-treated H9 cellline .j 608 to 1327 1 to 720       720/720
(100 %)
0 diff
(100 %id)
H54104 liver and spleen .j 620 to 985 1 to 374       374/415
(90 %)
8 diff
(98.1 %id)
CX873538 embryonic stem .j 623 to 1457 1 to 834       834/834
(100 %)
1 diff
(99.9 %id)
CF141536 CNCAP(3)T-225 cell line, Prostate .j 674 to 1104 1 to 431       431/431
(100 %)
4 diff
(99.1 %id)
FN105384 breast carcinoma .j 681 to 785 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
TI_154172293   .j 681 to 1547 91 to 934       844/997
(84 %)
83 diff
(91.7 %id)
BF965774 Bone, osteosarcoma, cell line .j 742 to 1517 1 to 768       768/795
(96 %)
21 diff
(97.4 %id)
BX482198   .j 757 to 1325 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BI252348 hepatocellular carcinoma, cell line, Liver .j 762 to 1277 1 to 515   fully sequenced,   515/515
(100 %)
12 diff
(97.7 %id)
BM741675 stomach .j 791 to 1375 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM744956 stomach .j 791 to 1353 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BU933542 mixed (pool of 40 RNAs) .j 793 to 1534 1 to 747       747/769
(97 %)
14 diff
(98.2 %id)
AA431134   .j 796 to 1126 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
BU163922 large cell carcinoma, lung .j 818 to 1381 1 to 571       571/1044
(54 %)
19 diff
(98.2 %id)
DA605001   .j 845 to 1401 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
BP225610   .j 852 to 1432 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CD358426 testis .j 859 to 1712 30 to 888       859/889
(96 %)
17 diff
(98.1 %id)
BQ215229 embryonal carcinoma, cell line, testis .j 860 to 1561 83 to 793       711/1024
(69 %)
34 diff
(96.7 %id)
BG112283 Bone, osteosarcoma, cell line .j 875 to 1452 1 to 585       585/1213
(48 %)
18 diff
(98.6 %id)
BG110174 Bone, osteosarcoma, cell line .j 885 to 1526 1 to 634   AAA   634/859
(73 %)
9 diff
(99.0 %id)
BX283736 adenocarcinoma cell line, colon .j 910 to 1407 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
BG824472 adenocarcinoma cell line, colon .j 910 to 1808 1 to 904       904/932
(96 %)
17 diff
(98.2 %id)
BM044968 carcinoma, cell line, Prostate .j 917 to 1768 1 to 849       849/852
(99 %)
10 diff
(98.9 %id)
BI870942 adenocarcinoma, cell line, Liver .j 918 to 1640 1 to 720       720/720
(100 %)
5 diff
(99.4 %id)
TI_57229891   .j 918 to 1640 87 to 806       720/720
(100 %)
5 diff
(99.4 %id)
CA455229   .j 919 to 1802 1 to 887       887/891
(99 %)
6 diff
(99.4 %id)
BM910268 astrocytoma grade IV, cell line, brain .j 925 to 1601 1 to 680       680/1036
(65 %)
7 diff
(99.4 %id)
BM823766 Ascites, stomach .j 937 to 1377 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
BM556917 melanotic melanoma, skin .j 943 to 1875 1 to 946       946/1042
(90 %)
36 diff
(96.6 %id)
CX782603 human embryonic stem cells .j 967 to 1768 1 to 802       802/802
(100 %)
0 diff
(100 %id)
BQ277355 mixed (pool of 40 RNAs) .j 983 to 1768 3 to 796       794/901
(88 %)
11 diff
(98.8 %id)
DW423736 Liver .j 999 to 1288 1 to 290       290/290
(100 %)
6 diff
(98.0 %id)
AI038260 liver and spleen .j 1006 to 1839 844 to 1       844/844
(100 %)
21 diff
(97.6 %id)
AW732512 Kidney, renal cell adenocarcinoma .j 1028 to 1596 1 to 567       567/567
(100 %)
3 diff
(99.5 %id)
AL516767 brain, neuroblastoma, neuroblastoma cells .j 1043 to 2104 1059 to 1   fully sequenced,   1059/1059
(100 %)
24 diff
(97.8 %id)
BM834359 stomach .j 1045 to 1648 1 to 604       604/604
(100 %)
0 diff
(100 %id)
TI_154125943   .j 1053 to 1839 865 to 90   AAA   776/907
(85 %)
17 diff
(98.2 %id)
BX363006   .j 1089 to 2088 983 to 1       983/1008
(97 %)
25 diff
(97.6 %id)
CB159790 Liver .j 1097 to 1589 1 to 493       493/493
(100 %)
0 diff
(100 %id)
TI_154126685   .j 1097 to 1843 824 to 86   AAA   739/908
(81 %)
12 diff
(98.7 %id)
BQ650541 hepatocellular carcinoma, cell line, Liver .j 1112 to 2071 7 to 974       968/980
(98 %)
38 diff
(96.2 %id)
AI917458 pooled germ cell tumors .j 1139 to 1837 700 to 1       700/705
(99 %)
14 diff
(98.1 %id)
H70678 liver and spleen .j 1145 to 1638 1 to 504       504/614
(82 %)
33 diff
(94.7 %id)
CA416768 Chondrosarcoma Cell line .j 1149 to 1843 714 to 19   AAA   696/696
(100 %)
3 diff
(99.6 %id)
AA628301   .j 1153 to 1555 405 to 3       403/405
(99 %)
0 diff
(100 %id)
AA291514 ovarian tumor, ovary .j 1156 to 1294 139 to 1       139/139
(100 %)
6 diff
(95.7 %id)
BI253020 hepatocellular carcinoma, cell line, Liver .j 1247 to 2045 818 to 1   fully sequenced,   818/818
(100 %)
40 diff
(95.2 %id)
AA432153   .j 1441 to 1846 410 to 5       406/410
(99 %)
0 diff
(100 %id)
DB358928 whole embryo, mainly body .j 1553 to 2115 558 to 1       558/561
(99 %)
28 diff
(95.1 %id)
Z39943 brain, total brain .j 1875 to 2115 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AA243133 brain, neuroepithelial cells .j 1950 to 2115 191 to 26   AAA   166/166
(100 %)
0 diff
(100 %id)
NM_198433.1   .k 1 to 2552 1 to 2552 exact RefSeq,   2552/2554
(99 %)
5 diff
(99.9 %id)
BG251277 adenocarcinoma, cell line, Liver .k 76 to 825 11 to 749   tiling clone,   739/936
(78 %)
27 diff
(97.2 %id)
DB128755 thymus .k 82 to 604 2 to 524   capped   523/523
(100 %)
3 diff
(99.5 %id)
DA666229   .k 93 to 596 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
CF123352 CNCAP(3)T-225 cell line, Prostate .k 100 to 774 1 to 665       665/667
(99 %)
19 diff
(97.2 %id)
BQ108618 carcinoma, cell line, Prostate .k 102 to 727 1 to 625       625/625
(100 %)
8 diff
(98.8 %id)
BI333250 cervical carcinoma cell line, cervix .k 103 to 937 1 to 835       837/835
(100 %)
14 diff
(98.4 %id)
BM043613 carcinoma, cell line, Prostate .k 105 to 685 1 to 582       582/606
(96 %)
4 diff
(99.4 %id)
BU542363 carcinoma, cell line, Prostate .k 107 to 941 1 to 834   tiling clone,   834/912
(91 %)
6 diff
(99.4 %id)
TI_154183287   .k 107 to 815 67 to 760       694/742
(93 %)
24 diff
(96.8 %id)
DB024437 testis .k 108 to 665 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
AA373999 lung .k 109 to 333 1 to 224       224/227
(98 %)
4 diff
(98.3 %id)
BQ224901 epithelioid carcinoma, Pancreas .k 110 to 893 1 to 788       788/903
(87 %)
12 diff
(98.7 %id)
BQ440632 melanotic melanoma, skin .k 110 to 945 1 to 839       839/875
(95 %)
11 diff
(98.8 %id)
DA005817   .k 111 to 596 2 to 487   capped   486/486
(100 %)
1 diff
(99.8 %id)
BX490483   .k 124 to 354 1 to 229       229/283
(80 %)
6 diff
(97.9 %id)
CN273681 embryonic stem cells, cell lines H1, H7, andH9 .k 128 to 596 11 to 479       469/479
(97 %)
6 diff
(98.8 %id)
CN273683 embryonic stem cells, DMSO-treated H9 cellline .k 152 to 665 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
DA617239   .k 162 to 609 2 to 450   capped   449/457
(98 %)
2 diff
(99.6 %id)
DA661105   .k 328 to 882 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
CN273675 embryonic stem cells, DMSO-treated H9 cellline .k 416 to 1177 1 to 762   tiling clone,   762/762
(100 %)
3 diff
(99.7 %id)
BQ220215 large cell carcinoma, lung .k 416 to 1287 1 to 872   tiling clone,   872/872
(100 %)
24 diff
(97.3 %id)
BE544022 cervical carcinoma cell line, cervix .k 458 to 1114 1 to 668       669/971
(68 %)
43 diff
(95.6 %id)
BI859800 breast, mammary adenocarcinoma, cell line .l 1 to 784 2 to 797 G21R P22S R24T V25C L26F ... tiling clone,   792/964
(82 %)
35 diff
(96.4 %id)
TI_57188872   .l 1 to 784 50 to 845 G21R P22S R24T V25C L26F ...     792/964
(82 %)
35 diff
(96.4 %id)
DB016678 esophageal, tumor tissue .m 1 to 521 2 to 523   tiling clone, capped   522/522
(100 %)
3 diff
(99.5 %id)
DA678674   .m 15 to 581 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA558807   .m 20 to 583 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
BU178941 eye, retinoblastoma .m 29 to 900 1 to 881 I57V K117X K119X K125R R126G ... tiling clone,   881/910
(96 %)
20 diff
(97.9 %id)
BG774380 choriocarcinoma, placenta .m 79 to 737 1 to 655       657/939
(69 %)
8 diff
(99.2 %id)
DA617240   .m 81 to 652 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BG248708 adenocarcinoma cell line, colon .m 83 to 816 1 to 731   tiling clone,   731/742
(98 %)
9 diff
(98.8 %id)
DA649428   .n 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
1 diff
(99.9 %id)
DB016352 esophageal, tumor tissue .n 37 to 407 2 to 372   capped   371/371
(100 %)
2 diff
(99.5 %id)
CA453270 mixed (pool of 40 RNAs) .n 49 to 784 1 to 747 F31I I57V N109D A129G L130F ... tiling clone,   747/749
(99 %)
25 diff
(96.7 %id)
DW467253 Liver .n 52 to 381 18 to 347       330/347
(95 %)
8 diff
(97.7 %id)
DB043320 testis .n 60 to 628 2 to 571   tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DW462608 Liver .n 61 to 416 13 to 367       355/367
(96 %)
8 diff
(97.9 %id)
DW408249 Liver .n 62 to 482 15 to 435       421/435
(96 %)
10 diff
(97.8 %id)
DB059295 testis .n 67 to 541 2 to 476   capped   475/475
(100 %)
2 diff
(99.6 %id)
BP353102   .o 1 to 584 1 to 583 I91V tiling clone,   583/583
(100 %)
3 diff
(99.5 %id)
DW451671 Liver .p 1 to 357 20 to 375 E46R A47P E48R V49W G50V ... tiling clone,   358/375
(95 %)
16 diff
(95.8 %id)
DW438416 Liver .p 50 to 278 17 to 245   tiling clone,   229/245
(93 %)
6 diff
(97.6 %id)
DA732446   .q 1 to 659 2 to 667   tiling clone, capped   666/666
(100 %)
24 diff
(96.4 %id)
G36678   .q 659 to 1246 1 to 589       589/589
(100 %)
9 diff
(98.5 %id)
N64029 liver and spleen .q 659 to 1246 1 to 589   tiling clone, Submitted on the opposite strand 589/589
(100 %)
9 diff
(98.5 %id)
DB363933   .q 1268 to 1805 532 to 1   tiling clone,   532/541
(98 %)
16 diff
(97.1 %id)
DA051644   .r 1 to 559 2 to 561   tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
DB072803 testis .r 22 to 573 2 to 554   capped   553/553
(100 %)
4 diff
(99.3 %id)
BP345701 synovial membrane .r 32 to 612 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP346390 synovial membrane .r 32 to 611 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
CB113289 Liver .r 43 to 497 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
DA752987   .r 63 to 632 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB059892 testis .r 65 to 497 2 to 435   capped   434/434
(100 %)
4 diff
(99.1 %id)
DA618557   .r 66 to 647 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BP366321   .r 71 to 652 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP366328   .r 72 to 655 1 to 583       583/583
(100 %)
6 diff
(99.0 %id)
CN273680 embryonic stem cells, cell lines H1, H7, andH9 .r 81 to 786 1 to 705 F31I I57V tiling clone,   705/705
(100 %)
3 diff
(99.6 %id)
DA479535   .r 84 to 630 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA748042   .r 85 to 662 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DB026656 testis .r 85 to 644 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB037208 testis .r 85 to 652 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA959780 Spleen .s 1 to 571 2 to 576 I57V tiling clone, capped   575/575
(100 %)
8 diff
(98.7 %id)
AK301769 testis Gene AURKA, variant not shown         Suspected internal deletion, this clone was ignored    
BC002499 Colon, adenocarcinoma Gene AURKA, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BE856617 pooled Gene AURKA, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM455942 lymph, lymphoma, cell line Gene AURKA, variant not shown         This clone was ignored    
CF146957 CNCAP(3)T-225 cell line, Prostate Gene AURKA, variant not shown         This clone was ignored    
CF147075 CNCAP(3)T-225 cell line, Prostate Gene AURKA, variant not shown         This clone was ignored    
DC395187 testis Gene AURKA, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI